Teratogenesis and Neurodevelopment on Antisei...

In part two of this series, Dr. Andy Southerland and Dr. Dan Ackerman discuss a few rapid‑fire concepts from the 2026 guidelines, focusing on what is new and how emerging data may shape patient care. Show transcript: Dr. Andy Southerland: Hello, everyone. This is Andy Southerland ...  Show more

In part one of this series, Dr. Andy Southerland and Dr. Dan Ackerman discuss what stands out in the latest thrombolysis guidelines, how these decisions are applied in stroke center practice, and how to educate residents and fellows on incorporating new evidence into treatment ch ...  Show more

Dr. Tesha Monteith talks with Dr. Alexandra Jean Sinclair about disease course and long-term outcomes in pregnant women with idiopathic intracranial hypertension.

Read the related article in <a href= "https://n.neurology.org/content/early/2023/02/07/WNL.0000000000206854 ...

Dr. Tesha Monteith talks with Dr. Peter Goadsby about updates on migraine treatments and the integration of CGRP inhibitors into clinical practice. Disclosures can be found at Neurology.org 

Dr. Dan Ackerman talks with Dr. Andy Southerland about the impact of glucose control on the risk of symptomatic intracerebral hemorrhage following thrombolysis for acute ischemic stroke. Read the related article in Neurology.  This podcast is sponsored by argenx. Visit www.vyvgar ...  Show more

Interview with Raj K Maturi, MD, and Jennifer K Sun, MD, authors of Effect of Intravitreous Anti–Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical Trial and with Howa ...  Show more